Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be a minor maintenance update. No substantive study content or fields appear to be altered.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now includes a dedicated Locations section with sites in Alabama, Arizona, California, New York, Ohio, Oklahoma, Texas, and Washington, plus an updated revision tag (v3.3.3). The HHS Vulnerability Disclosure link was removed.SummaryDifference0.9%

- Check50 days agoChange DetectedThe revision label in the page footer updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check57 days agoChange DetectedRemoved the administrative notice banner about a lapse in government funding and NIH operating status. The study details and trial information shown on the page remain the same.SummaryDifference0.4%

- Check72 days agoChange DetectedResults data for the study were posted, including primary and secondary outcomes across ABI, SRS-2, ABC, CGI scales, and related measures. The record dates show Results First Posted on 2025-04-23 and subsequent updates.SummaryDifference0.4%

- Check101 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference2%

Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.